Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bastien Marti"'
Autor:
Benjamin O. Tschumi, Nina Dumauthioz, Bastien Marti, Lianjun Zhang, Pascal Schneider, Jean-Pierre Mach, Pedro Romero, Alena Donda
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-9 (2018)
Abstract Adoptive transfer of T cells transduced with Chimeric Antigen Receptors (CAR) are now FDA-approved for the treatment of B-cell malignancies. Yet, the functionality of the endogenous TCR in CART cells has not been fully assessed. Here, we dem
Externí odkaz:
https://doaj.org/article/e1db79a0f0f14cd1a7f6e87f27f828d5
Autor:
Benjamin O. Tschumi, Nina Dumauthioz, Bastien Marti, Lianjun Zhang, Evripidis Lanitis, Melita Irving, Pascal Schneider, Jean-Pierre Mach, George Coukos, Pedro Romero, Alena Donda
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-1 (2018)
After publication of this article [1], it was noticed that 3 authors were missed from the author list.
Externí odkaz:
https://doaj.org/article/6650641df31a40a8b63e505386c1c465
Autor:
Haiping Wang, Isabel C. Lopez-Mejia, Mathias Wenes, Bastien Marti, Nina Dumauthioz, Pedro Romero, Wenhui Li, Benjamin O. Tschumi, Alena Donda, Lluis Fajas, Ping-Chih Ho, Fabien Franco, Lianjun Zhang
Publikováno v:
Cellular and Molecular Immunology
Cellular & molecular immunology, vol. 18, no. 7, pp. 1761-1771
Cellular & molecular immunology, vol. 18, no. 7, pp. 1761-1771
Memory CD8 T cells can provide long-term protection against tumors, which depends on their enhanced proliferative capacity, self-renewal and unique metabolic rewiring to sustain cellular fitness. Specifically, memory CD8 T cells engage oxidative phos
Autor:
Hippolyte Darré, Perrine Masson, Arnaud Nativel, Laura Villain, Diane Lefaudeux, Claire Couty, Bastien Martin, Evgueni Jacob, Michaël Duruisseaux, Jean-Louis Palgen, Claudio Monteiro, Adèle L’Hostis
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 704 (2024)
Mutationsin epidermal growth factor receptor (EGFR) are found in approximately 48% of Asian and 19% of Western patients with lung adenocarcinoma (LUAD), leading to aggressive tumor growth. While tyrosine kinase inhibitors (TKIs) like gefitinib and os
Externí odkaz:
https://doaj.org/article/e5edff8536c445b9bec0eb00a9ed4bd5
Autor:
George Coukos, Pedro Romero, Alena Donda, Lianjun Zhang, Melita Irving, Benjamin O. Tschumi, Nina Dumauthioz, Jean-Pierre Mach, Pascal Schneider, Evripidis Lanitis, Bastien Marti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-1 (2018)
Journal for Immunotherapy of Cancer, vol. 6, no. 1, pp. 92
Journal for Immunotherapy of Cancer, vol. 6, no. 1, pp. 92
After publication of this article [1], it was noticed that 3 authors were missed from the author list.